atenolol has been researched along with atrial natriuretic factor in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (35.71) | 18.7374 |
| 1990's | 10 (35.71) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DS; Turkkan, JS | 1 |
| Kohno, M; Kurihara, N; Murakawa, K; Takeda, T; Yasunari, K; Yokokawa, K | 1 |
| Bucci, V; Casale, R; Colantonio, D; Desiati, P; Giandomenico, G; Pasqualetti, P | 1 |
| al-Obaidi, M; Karim, F; Whitaker, EM | 1 |
| Bune, AJ; Cain, MD; Chalmers, J; Morris, MJ; Russell, AE; Tonkin, AL; West, MJ; Wing, LM | 1 |
| Berlin, I; Carayon, A; Deray, G; Legrand, JC; Legrand, S; Maistre, G; Martinez, F; Masson, F; Prost, A; Puech, A | 1 |
| King, KA; Ledsome, JR | 1 |
| Ernst, JE; Gerzer, R; Haufe, MC; Heim, JM; Theisen, K; Weil, J | 1 |
| Bune, AJ; Cain, MD; Chalmers, JP; Morris, MJ; Russell, AE; Southgate, DO; West, MJ; Wing, LM | 1 |
| Bune, AJ; Chalmers, JP; Elliott, JM; Morris, MJ; Russell, AE; West, MJ; Wing, LM | 1 |
| Bennett, KL; Linden, RJ | 1 |
| Courneya, CA; Ledsome, JR; Rankin, AJ; Wilson, N | 2 |
| Leenen, FH; Nguyen, PV; Smith, DL | 1 |
| Andersson, OK; Hedner, J; Hedner, T; Persson, B; Pettersson, A; Towle, AC; Wysocki, M | 1 |
| Keller, N; Larsen, J; Storm, T; Sykulski, R; Thamsborg, G | 1 |
| Amano, M; Fujii, J; Imataka, K; Ishibashi, M; Kitahara, Y; Nakaoka, H; Yamaji, T | 1 |
| Kaila, T; Kantola, I; Ruskoaho, H; Scheinin, M; Tarssanen, L; Viinamäki, O | 1 |
| Elijovich, F; Laffer, CL; Schiffrin, EL | 1 |
| Alaupovic, P; Bichet, D; Bielmann, P; Cartier, P; Lupien, PJ; Marc-Aurèle, J; Pesant, Y; Thibault, G | 1 |
| Berger, R; Bergler-Klein, J; Bojic, A; Frey, B; Hartter, E; Hülsmann, M; Moser, P; Pacher, R; Stanek, B; Strametz-Juranek, J; Sturm, B | 1 |
| Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
| Baldini, PM; De Vito, P; Di Nardo, P; Fraziano, M; Luly, P; Mattioli, P | 1 |
| Chaulet, H; Du, XJ; Fang, L; Feng, X; Finch, AM; Gao, XM; Graham, RM; Hotchkin, E; Kiriazis, H | 1 |
| Bang, LE; Devereux, RB; Fossum, E; Hall, C; Hildebrandt, PR; Ibsen, H; Olsen, MH; Rokkedal, J; Tuxen, C; Wachtell, K | 1 |
| Dahlöf, B; Devereux, RB | 1 |
| Bell, D; Devine, AB; McDermott, BJ; Zhao, YY | 1 |
| Peuhkurinen, K; Peuhkurinen, S; Risteli, J; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
1 review(s) available for atenolol and atrial natriuretic factor
| Article | Year |
|---|---|
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiovascular Agents; Cohort Studies; Drug Utilization; Endothelium, Vascular; Follow-Up Studies; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Models, Biological; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Precursors; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Stroke; Thrombosis; Treatment Outcome | 2007 |
13 trial(s) available for atenolol and atrial natriuretic factor
| Article | Year |
|---|---|
Acute effects of alpha- and beta-adrenoceptor blockade on plasma atrial natriuretic peptides during exercise in elderly patients with mild hypertension.
Topics: Aged; Atenolol; Atrial Natriuretic Factor; Carteolol; Exercise; Female; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prazosin; Ventricular Function, Left | 1991 |
Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension.
Topics: Adult; Aldosterone; Atenolol; Atrial Natriuretic Factor; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Renin | 1991 |
Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy.
Topics: Atenolol; Atrial Natriuretic Factor; Blood Pressure; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Heart Conduction System; Heart Rate; Humans; Hypertension | 1990 |
Beta-adrenoceptor blockade potentiates exercise-induced release of atrial natriuretic peptide.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Atrial Natriuretic Factor; Double-Blind Method; Exercise; Humans; Male; Propanolamines; Thiophenes | 1990 |
Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions.
Topics: Angiotensin II; Atenolol; Atrial Natriuretic Factor; Double-Blind Method; Drug Therapy, Combination; Enalapril; Factor Analysis, Statistical; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Random Allocation; Renin | 1987 |
Acute volume loading, atrial natriuretic peptide release and cardiac function in healthy men. Effects of beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Atrial Natriuretic Factor; Blood; Blood Pressure; Cardiac Volume; Heart; Hematocrit; Humans; Male; Osmolar Concentration; Plasma Volume; Propranolol; Saline Solution, Hypertonic; Sodium; Stroke Volume | 1988 |
Atrial natriuretic peptide during exercise in patients with coronary heart disease before and after single dose atenolol and acebutolol.
Topics: Acebutolol; Aged; Atenolol; Atrial Natriuretic Factor; Clinical Trials as Topic; Coronary Disease; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation | 1988 |
beta-blockade, atrial natriuretic peptide and exercise.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Epinephrine; Exercise Test; Humans; Male; Norepinephrine; Pindolol; Propranolol; Vasopressins | 1996 |
The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.
Topics: Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Captopril; Double-Blind Method; Drug Interactions; Hemodynamics; Humans; Hypertension | 1997 |
Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
Topics: Adrenocorticotropic Hormone; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Benzopyrans; Blood Pressure; Double-Blind Method; Ethanolamines; Female; Heart Rate; Humans; Hydrocortisone; Hypertension; Lipids; Male; Middle Aged; Nebivolol; Time Factors | 1999 |
Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Atenolol; Atrial Natriuretic Factor; Biomarkers; Double-Blind Method; Endothelin-1; Endothelins; Female; Heart Failure; Hormones; Humans; Male; Middle Aged; Norepinephrine; Placebos; Prognosis; Proportional Hazards Models; Protein Precursors; Random Allocation; Risk Factors; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
Topics: Aged; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments | 2005 |
Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Biomarkers; Collagen; Collagen Type I; Humans; Hypertension; Natriuretic Peptide, Brain; Peptide Fragments; Peptides; Procollagen; Ventricular Remodeling | 2011 |
14 other study(ies) available for atenolol and atrial natriuretic factor
| Article | Year |
|---|---|
Stress and sodium hypertension in baboons: neuroendocrine and pharmacotherapeutic assessments.
Topics: Animals; Atenolol; Atrial Natriuretic Factor; Creatinine; Dopamine; Epinephrine; Hydrochlorothiazide; Hydrocortisone; Hypertension; Male; Norepinephrine; Osmolar Concentration; Papio; Renin; Sodium; Sodium, Dietary; Stress, Physiological; Vasopressins | 1991 |
The effect of discrete stimulation of carotid body chemoreceptors on atrial natriuretic peptide in anaesthetized dogs.
Topics: Anesthesia; Animals; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Carotid Sinus; Chemoreceptor Cells; Dogs; Female; Male; Sodium | 1991 |
The effect of tachycardia on right atrial dynamics and plasma atrial natriuretic factor in anaesthetized rabbits.
Topics: Anesthesia, Intravenous; Animals; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Heart; Heart Atria; Heart Rate; Male; Rabbits; Tachycardia | 1990 |
[Hemodynamic and medicamentous modification of stimulated atrial natriuretic factor secretion].
Topics: Adult; Aged; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Disease; Cyclic GMP; Female; Humans; Male; Middle Aged; Molsidomine; Verapamil | 1989 |
Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination.
Topics: Aldosterone; Angiotensin II; Atenolol; Atrial Natriuretic Factor; Drug Interactions; Drug Therapy, Combination; Enalapril; Heart Rate; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin | 1988 |
Diuresis from atrial receptors after hypophysectomy and local ablation with no changes in plasma vasopressin.
Topics: Animals; Arginine Vasopressin; Atenolol; Atrial Natriuretic Factor; Atropine; Diuresis; Dogs; Hypophysectomy; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Reference Values; Sodium | 1988 |
Tachycardia releases atrial natriuretic peptide in the anesthetized rabbit.
Topics: Acetylcholine; Animals; Atenolol; Atrial Natriuretic Factor; Atropine; Blood Pressure; Cardiac Pacing, Artificial; Heart Atria; Heart Rate; Hexamethonium; Hexamethonium Compounds; Isoproterenol; Male; Rabbits; Tachycardia | 1986 |
Increase in plasma atrial natriuretic peptides during acute volume expansion in hypertensive man.
Topics: Atenolol; Atrial Natriuretic Factor; Blood Volume; Diuresis; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Natriuresis; Sodium Chloride | 1986 |
Time course of release of atrial natriuretic peptide in the anaesthetized dog.
Topics: Animals; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Coronary Vessels; Dogs; Femoral Artery; Heart Atria; Myocardium; Sympathetic Nervous System; Vagotomy | 1986 |
Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension.
Topics: Acebutolol; Adult; Aged; Aldosterone; Atenolol; Atrial Natriuretic Factor; Cyclic GMP; Female; Humans; Hypertension; Male; Middle Aged; Renin | 1987 |
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic | 2001 |
Atrial natriuretic factor inhibits mitogen-induced growth in aortic smooth muscle cells.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Atenolol; Atrial Natriuretic Factor; Cell Cycle; Cell Division; Cells, Cultured; DNA; Flow Cytometry; Insulin; Male; Mitogens; Muscle, Smooth, Vascular; Phosphatidic Acids; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Signal Transduction | 2002 |
Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.
Topics: Actins; Animals; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Myosins; Cardiac Output, Low; Constriction; Electrocardiography; Gene Expression; Genetic Enhancement; Hypertrophy, Left Ventricular; Mice; Mice, Transgenic; Myocardial Contraction; Myosin Light Chains; Receptors, Adrenergic, alpha-1; Ventricular Function | 2004 |
Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components.
Topics: Adrenomedullin; Animals; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Endothelin-1; Gene Expression Regulation; Hypertrophy; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Neuropeptides; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Oxidative Stress; Peptides; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Protein 2; Receptor Activity-Modifying Protein 3; Receptor Activity-Modifying Proteins; Receptors, Cell Surface; Systole | 2008 |